Neurology Patient Monitoring Market Size, Share, Growth, and Industry Analysis, By Type (Trauma,CSF Management,Migraine,Stroke,Hydrocephalus,EEG), By Application (hospital,clinic), Regional Insights and Forecast to 2035

Neurology Patient Monitoring Market Overview

The global Neurology Patient Monitoring Market is forecast to expand from USD 7005.03 million in 2026 to USD 7435.14 million in 2027, and is expected to reach USD 11972.06 million by 2035, growing at a CAGR of 6.14% over the forecast period.

The global Neurology Patient Monitoring Market Size was estimated at approximately USD 4.0 billion in 2021, with the trauma application segment commanding roughly 24.6% revenue share that year. North America held about 37.9% share in 2021, with an estimated 1.7 million traumatic brain injuries (TBI) in the U.S. annually influencing device demand. The Neurology Patient Monitoring Market Outlook shows stroke incidence of approximately 15 million cases globally each year, of which ~5 million result in death and ~5 million in permanent disability — all driving monitoring demand. The Neurology Patient Monitoring Market Trends indicate that devices for intracranial pressure (ICP) monitoring, continuous EEG, and transcranial Doppler are rapidly being adopted across neurosurgical and neuro-ICU settings.

In the U.S. market, the Neurology Patient Monitoring Market Research Report notes that the U.S. neurology monitoring segment was estimated at around USD 1.6 billion in 2022, representing more than ~40% of the global market. The U.S. sees approximately 800,000 strokes per year, and about 3 million non-fatal TBIs annually, boosting demand for monitoring equipment. Federal initiatives for stroke awareness and cerebral injury monitoring have increased adoption rates by over 30% in the past five years. The U.S. Neurology Patient Monitoring Market Analysis shows that ICU neurology monitoring penetration in large hospitals exceeded 78% in 2023, compared to 63% in 2018.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 16 million people worldwide suffer a stroke annually, fueling demand for neurology monitoring in acute hospital settings.
• Major Market Restraint: Device cost and training barriers restrict adoption in roughly 45% of mid-sized hospitals globally.
• Emerging Trends: Use of wearable neurology monitoring devices increased by about 23% year-on-year in 2023 across developed markets.
• Regional Leadership: North America held about 37.9% share of the Neurology Patient Monitoring Market in 2021, leading globally in uptake.
• Competitive Landscape: The top five players control over 42% of device shipments in 2023, indicating moderate market concentration.
• Market Segmentation: Trauma accounted for approximately 24.6% of application share in 2021, making it the largest segment in Neurology Patient Monitoring Market Report.
• Recent Development: In 2024 more than 10 new neurology monitoring platforms were launched globally, representing about 12% of all neuromonitoring device launches that year.

Neurology Patient Monitoring Market Latest Trends

In 2023, the Neurology Patient Monitoring Market Trends indicate that the trauma monitoring segment maintained its leadership position with nearly 24–25% share, supported by rising trauma incidence such as ~1.7 million TBIs in the U.S. annually. The stroke monitoring segment has expanded with the global stroke burden of ~15 million cases annually—resulting ~5 million deaths and ~5 million permanent disabilities—pushing hospitals to adopt neurology monitors broadly. The growing deployment of continuous EEG (cEEG) and intracranial pressure (ICP) monitoring systems is significant: hospitals reported a ~19% increase in cEEG utilization in neuro-ICUs between 2021 and 2023. Remote neurology patient monitoring systems and tele-ICU monitoring platforms saw uptake growth of about 26% year-on-year in 2023, as clinics and smaller hospitals sought cost-effective monitoring. Wearable neurology sensors and home EEG units increased presence, making up about 14% of new product registrations in 2023. The Asia-Pacific region registered a rapid acceleration in neurology monitoring adoption: the regional share rose from ~22% in 2021 to ~28% in 2023, driven by rising neurological disease prevalence and expanding hospital networks. The Neurology Patient Monitoring Market Analysis also points to an increase in minimally invasive neurology monitoring devices, which recorded ~17% growth in unit shipments in 2023. These trends underpin growing demand and highlight opportunities for new entrants and established players in the neurology patient monitoring space.

Neurology Patient Monitoring Market Dynamics

The Market Dynamics of the Global Neurology Patient Monitoring Market reflect the combined influence of drivers, restraints, opportunities, and challenges shaping its expansion and technological evolution. The market, valued at USD 6,599.8 million in 2025, is projected to reach USD 11,279.5 million by 2034, indicating sustained global demand for advanced neurological diagnostic and monitoring solutions. A major driver includes the rising incidence of neurological disorders—such as stroke, affecting over 15 million people annually, and traumatic brain injuries, with more than 69 million global cases each year—propelling adoption of continuous EEG and intracranial pressure (ICP) monitoring devices. However, restraints such as high equipment costs, which can exceed USD 25,000 per unit, and limited reimbursement coverage across 40% of developing nations, hinder widespread hospital adoption. On the other hand, opportunities are emerging in tele-neurology and portable monitoring devices, with over 20% of hospitals worldwide investing in remote neurology monitoring systems in 2024. Yet, challenges persist in interoperability, with nearly 45% of healthcare facilities citing data integration issues across neurology devices. Collectively, these dynamics define the market’s strategic direction, driving steady growth while pushing manufacturers toward innovations in wireless, AI-driven, and cost-effective neurology patient monitoring technologies.

DRIVER

"Rising prevalence of neurological disorders and trauma-related brain injuries"

The main driver for the Neurology Patient Monitoring Market Growth is the increasing frequency of neurological disorders and brain injuries. Globally, approximately 1.7 million people sustain a traumatic brain injury (TBI) each year in the U.S. alone, with worldwide numbers more than 69 million annually according to recent estimates. Stroke incidents affect roughly 15 million people annually, of which about 5 million die and another 5 million are left disabled, directly contributing to neurology monitoring device demand. Aging populations also play a role—over 55% of all strokes occur in people over age 65—and neurodegenerative conditions like Alzheimer’s and Parkinson’s combine to exceed 50 million individuals globally, all increasing monitoring needs. Hospitals in North America reported neurology monitoring system adoption rates of over 78% in high-tier hospitals as of 2023. The Neurology Patient Monitoring Market Report indicates that the rise in road accidents, sports-related head injuries, and ICU neurosurgical procedures is stimulating demand for neurology patient monitoring equipment in acute care settings.

RESTRAINT

" High acquisition cost, specialized training and limited reimbursement access"

One major restraint affecting the Neurology Patient Monitoring Market is high capital cost of equipment and the need for specialized training. Monitoring systems such as ICP monitors, transcranial Doppler devices and continuous EEG units can cost up to 3-5 times the cost of conventional vital-sign monitors. Many smaller hospitals and clinics report that less than 55% of neurologic monitoring devices are reimbursed by insurance or public healthcare in emerging markets. Training requirements for neurology patient monitoring in neuro-ICU settings mean clinician proficiency is often limited: only around 60% of hospitals globally have dedicated neuromonitoring staff as of 2022. The result is slower adoption in mid- and lower-tier facilities; adoption in rural hospitals is estimated at less than 22% in some regions. The Neurology Patient Monitoring Market Research Report notes that delays in regulatory approvals for neuromonitoring devices in certain geographies further restrict access and uptake.

OPPORTUNITY

"Growth in portable/remote monitoring, tele-neurology and emerging markets"

A substantial opportunity exists in the Neurology Patient Monitoring Market via remote and portable monitoring systems, tele-neurology, wearable neurology sensors and emerging market expansion. Wearables and home EEG units grew by approximately 14% in new product launches in 2023, offering monitoring beyond hospital settings. Tele-ICU and tele-neurology services increased by around 26% year-on-year in 2023, reflecting demand for remote patient monitoring in neurology. In emerging markets (Asia-Pacific, Latin America, MEA), neurology patient monitoring penetration is still below 30% in many hospitals, representing substantial upside. For instance, in Asia-Pacific neurology monitoring share rose from ~22% to ~28% regionally between 2021 and 2023. Partnerships between device makers and local health systems are increasing; in 2023 more than 15 new collaborations were announced for neurological monitoring in Asia. These opportunities are highlighted in the Neurology Patient Monitoring Market Opportunities section, encouraging investment in compact, cost-effective monitoring solutions and service models for remote neurology care.

CHALLENGE

"Data integration, interoperability and device fragmentation"

A major challenge in the Neurology Patient Monitoring Market is achieving seamless data integration and interoperability across neurology monitoring systems and hospital networks. Many hospitals report that only around 48% of neurology monitoring devices are compatible with existing hospital IT/EMR systems. Fragmentation of devices—different vendors for EEG, ICP, TCD, and other neurology monitors—creates complexity in workflows; about 37% of neuro-ICUs cite device-integration issues in audits. The Neurology Patient Monitoring Market Industry Analysis highlights that limited standardization, cybersecurity concerns and lack of unified data platforms slow broader adoption. Additionally, many neurology monitoring system manufacturers face regulatory and reimbursement uncertainty in emerging markets, impacting commercialisation schedules; fewer than 40% of device launches in these regions succeed in reaching full market commercialisation within two years.

Neurology Patient Monitoring Market Segmentation

The Neurology Patient Monitoring Market Segmentation can be categorized by type (application category) and end-use application setting. By type we consider trauma, CSF management, migraine, stroke, hydrocephalus, EEG; by application we consider hospital and clinic settings. These segmentation divisions help to map market size, share and dynamics across multiple clinical workflows and device categories.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Trauma: The trauma segment of the Neurology Patient Monitoring Market pertains to monitoring systems used for TBI, head injury and acute neurosurgical trauma. In 2021, trauma held ~24.6% share of the global market, driven by road accidents, sports injuries and violence-related brain trauma; in the U.S. alone ~1.7 million TBIs occur annually, with ~1.3 million emergency-room visits. Hospitals have increasingly adopted intracranial pressure (ICP) monitoring systems and continuous EEG in trauma wards; between 2019-2023 trauma-monitoring device shipments grew by ~21%. The Neurology Patient Monitoring Market Trends show that portable neuromonitoring carts for trauma units began adoption in more than 230 hospitals in North America by 2023.

CSF Management: The CSF (cerebrospinal fluid) management segment includes devices for monitoring hydrocephalus, shunt pressure, cerebral herniation and CSF flow. Cases of hydrocephalus are estimated at around 0.5 to 1 per 1000 live births globally and prevalence in adults is rising; adoption of shunt-monitoring devices increased ~12% annually between 2020-2023. The Neurology Patient Monitoring Market Analysis identifies CSF management as a mid-sized segment, estimated at ~14% share in 2021, with growth driven by aging populations and increased neurosurgical procedures.

Migraine: The migraine monitoring segment focuses on monitoring cerebral hemodynamics, EEG biofeedback and neuro-modulation platforms after migraine attacks. Global migraine prevalence exceeds 1 billion people, with around 156 million disability-adjusted life years (DALYs) lost annually. The Neurology Patient Monitoring Market Research Report indicates the migraine segment held around ~10% share in 2022, and monitoring platform adoption rose by ~17% in neurology clinics in 2023.

Stroke: The stroke segment involves monitoring cerebral blood flow, transcranial Doppler, neuro-ICU ICP monitors and continuous EEG for stroke patients. With ~15 million strokes globally each year, and ~5 million deaths, stroke monitoring accounts for roughly ~23% of market share in 2021 according to research. Between 2020-2023, stroke monitoring system shipments increased by ~19% annually, especially in regions where neuro-ICUs expanded. The Neurology Patient Monitoring Market Size in stroke category is therefore one of the largest sub-segments.

Hydrocephalus: The hydrocephalus type overlaps with CSF but is treated separately; adult normal-pressure hydrocephalus affects ~700,000 individuals in the U.S. and pediatric hydrocephalus affects ~0.6 per 1000 births. The hydrocephalus monitoring devices segment was estimated at ~8% share in 2021; monitoring solutions are now being used in more than 120 hospitals in Europe for revision procedures and shunt monitoring. The Neurology Patient Monitoring Market Growth in this sub-segment is moderate but steady.

EEG: The electroencephalogram (EEG) monitoring segment comprises continuous EEG monitoring, ambulatory EEG and wearables. EEG devices are used in epilepsy, sleep disorders, ICU neurology and ambulatory neurology clinics. Global epilepsy affects ~50 million people; in 2022 more than 3 million EEGs were performed annually in the U.S. The EEG segment held about ~20% of the neurology monitoring market in 2022 and unit shipments increased by ~18% between 2021-2023. The Neurology Patient Monitoring Market Report indicates that ambulatory EEG adoption in neurology clinics rose from ~32% to ~39% between 2019 and 2023.

BY APPLICATION

Hospital: The hospital end-use application holds the largest portion of the Neurology Patient Monitoring Market due to acute care demand, neurosurgical ICUs, trauma centres and monitoring suites; in 2022 hospital adoption represented approximately 64% of device placements, with more than 78% of high-tier neuro-ICUs equipped with multi-parameter neurology monitoring systems by 2023. Annual hospital neurology monitoring device purchases increased ~22% between 2020-2023.

Clinic: The clinic setting includes neurology outpatient clinics, ambulatory monitoring centres and remote neurology monitoring services; cinema adoption in clinics rose by ~15% year-on-year in 2023 as fewer than 38% of clinics were previously equipped in 2018. Portable and home-based monitoring units grew ~26% between 2021-2023 in clinics. The Neurology Patient Monitoring Market Insights reveal that clinics are increasingly using EEG wearables and tele-monitoring platforms, representing ~36% of new product placements in 2023.

Regional Outlook for the Neurology Patient Monitoring Market

The Regional Outlook of a market refers to the analytical assessment of how industry performance, market size, and growth potential vary across different geographical regions. It highlights regional differences in demand, technological adoption, infrastructure, healthcare expenditure, and government support influencing market expansion. In the context of the Neurology Patient Monitoring Market, the regional outlook provides insights into how key regions — North America, Europe, Asia-Pacific, and the Middle East & Africa — contribute to overall market growth.

This includes analyzing regional market share, patient demographics, disease prevalence, and innovation intensity in medical technology. For example, in 2025, the Global Neurology Patient Monitoring Market is valued at USD 6,599.8 million, expanding to USD 11,279.5 million by 2034, with North America leading at approximately 39.2% market share, followed by Europe (28.0%), Asia-Pacific (26.4%), and the Middle East & Africa (6.4%). Each region’s growth is influenced by unique healthcare factors — such as higher neurological disorder rates in developed economies, rapid hospital infrastructure expansion in Asia, and emerging tele-neurology programs in the Middle East. Thus, the Regional Outlook helps identify where the strongest opportunities, competitive advantages, and technological adoptions exist within the global Neurology Patient Monitoring Market landscape.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominated the Neurology Patient Monitoring Market with approximately 37.9% share in 2021. The U.S. alone contributes nearly 90% of the regional total, driven by dense hospital networks, trauma centres and high neurology monitoring penetration. For instance, in the U.S., more than 1.7 million TBIs occur annually, more than 800,000 strokes, and over 3 million neuro ICU admissions each year, all fueling demand. Hospital adoption of neuro-monitoring systems reached ~78% in major centres by 2023. The North American market also leads in exports of neurology monitoring technology and has over 220 device manufacturers operating.

The North American Neurology Patient Monitoring Market is estimated at USD 2,585.4 million in 2025, projected to reach USD 4,269.1 million by 2034, representing 39.2% of the global share and advancing at a 6.11% growth rate, driven by strong adoption of EEG and ICP monitoring systems across neuro-ICUs and stroke centers.

North America – Major Dominant Countries in the “Neurology Patient Monitoring Market”

• United States: USD 1,984.7 million (76.7% regional share), 6.1% growth, supported by over 800,000 stroke cases and 1.7 million TBI incidents each year driving neurological monitoring equipment demand.
• Canada: USD 329.2 million (12.7% share), 6.0% growth, led by neurology program expansion in tertiary hospitals and government stroke-care initiatives.
• Mexico: USD 152.8 million (5.9% share), 6.2% growth, supported by modernization of neuro diagnostic centers and rising import of portable EEG systems.
• Cuba: USD 66.5 million (2.6% share), 6.0% growth, driven by state-funded neurosurgery facilities and adoption of local monitoring manufacturing.
• Costa Rica: USD 52.2 million (2.1% share), 6.1% growth, due to expanding critical-care neurology departments and cross-border training programs.

EUROPE

In Europe, the Neurology Patient Monitoring Market captured approximately 28% share in 2021, with Germany, U.K., France, Italy and Spain accounting for over 65% of the European total. Approximately 10 million people in the U.K. live with neurological conditions, prompting demand for neurology monitors. Adult hydrocephalus cases in Germany exceed 200,000 annually, and stroke incidence is about 1.1 million per year in Europe. European hospitals reported neurology monitoring device adoption rates of ~68% in tertiary centres by 2023, while clinic adoption grew ~16% annually between 2020-2023.

The European Neurology Patient Monitoring Market is valued at USD 1,845.9 million in 2025 and expected to reach USD 3,116.4 million by 2034, accounting for 28.0% of global share, rising steadily at a 6.10% growth rate supported by aging populations and high stroke and dementia prevalence across EU countries.

Europe – Major Dominant Countries in the “Neurology Patient Monitoring Market”

• Germany: USD 524.8 million (28.4% regional share), 6.1% growth, driven by neurology unit automation and hydrocephalus monitoring adoption across clinical settings.
• United Kingdom: USD 398.3 million (21.6% share), 6.1% growth, supported by National Health Service neurology infrastructure and stroke rehabilitation investments.
• France: USD 352.4 million (19.1% share), 6.0% growth, driven by EEG system modernization and tele-neurology service expansion.
• Italy: USD 295.6 million (16.0% share), 6.0% growth, supported by rising neurological disorder cases and government-funded neuro-ICU installations.
• Spain: USD 274.8 million (14.9% share), 6.1% growth, propelled by increasing stroke monitoring units and hospital equipment upgrades.

ASIA-PACIFIC

The Asia-Pacific region is emerging strongly in the Neurology Patient Monitoring Market, with share rising from ~22% in 2021 to ~28% by 2023. Countries such as China, India, Japan, South Korea and Australia collectively account for over 70% of the regional volume. China alone experienced over 2.3 million strokes in 2022, and India sees about 1.2 million TBIs annually, prompting heavy monitoring uptake. Hospital neurology monitoring adoption in Asia-Pacific reached ~54% in 2023, up from ~43% in 2018. Clinic-based portable neurology monitoring grew ~30% year-on-year between 2021-2023. The region also hosts more than 120 new monitoring device manufacturing sites and increasing local OEM competition. The Neurology Patient Monitoring Market Forecast shows that Asia-Pacific offers highest incremental growth opportunity among regions.

The Asian Neurology Patient Monitoring Market is valued at USD 1,743.6 million in 2025 and is forecasted to reach USD 3,175.5 million by 2034, holding a 26.4% global share and advancing at a 6.18% growth rate, driven by expanding hospital infrastructure and rising cases of stroke and epilepsy across emerging economies.

Asia – Major Dominant Countries in the “Neurology Patient Monitoring Market”

• China: USD 678.3 million (38.9% regional share), 6.2% growth, supported by high stroke incidence (~2.3 million cases annually) and large-scale neurology equipment production.
• Japan: USD 391.4 million (22.4% share), 6.1% growth, driven by aging population and integration of AI-based EEG platforms in hospitals.
• India: USD 314.7 million (18.0% share), 6.2% growth, supported by increased neuro-ICU expansions and TBI monitoring installations.
• South Korea: USD 195.8 million (11.2% share), 6.1% growth, propelled by investments in digital neuro-diagnostics and stroke care centers.
• Australia: USD 163.4 million (9.4% share), 6.0% growth, driven by rising neurology monitoring demand in aged care and ICU facilities.

MIDDLE EAST & AFRICA

The Middle East & Africa (MEA) region currently holds a smaller share—estimated at around 11% of global market volume in 2021—but is one of the fastest growth areas. The region records rising incidence of neurological conditions thanks to improved healthcare access; for example, the UAE has launched more than 5 national initiatives in neurology monitoring in 2022-2023. Hospital monitoring adoption in the MEA neuro-ICU sector increased from ~21% in 2018 to ~39% in 2023. Clinics in South Africa and Saudi Arabia report year-on-year growth of ~17% in neurology monitoring system purchases. Device manufacturers have established more than 8 regional service hubs in MEA in the last two years. While capital budgets are lower and reimbursement limited (applicants report less than 29% reimbursement rate), international collaborations and medical-tourism growth support demand. The Neurology Patient Monitoring Market Opportunities in MEA are strong especially in tele-neurology and portable monitoring solutions.

The Middle East and Africa Neurology Patient Monitoring Market is valued at USD 425.0 million in 2025, expected to reach USD 718.5 million by 2034, holding a 6.4% global share and advancing at a 6.10% growth rate, driven by rising neurology infrastructure investments and government stroke and TBI programs.

Middle East and Africa – Major Dominant Countries in the “Neurology Patient Monitoring Market”

• United Arab Emirates: USD 137.4 million (32.3% regional share), 6.2% growth, driven by neurology infrastructure modernization and hospital capacity expansion.
• Saudi Arabia: USD 119.6 million (28.1% share), 6.1% growth, supported by government healthcare initiatives and hospital neuro-ICU installations.
• South Africa: USD 82.9 million (19.5% share), 6.0% growth, propelled by stroke rehabilitation center growth and EEG unit deployment.
• Egypt: USD 56.7 million (13.3% share), 6.1% growth, driven by neuro-trauma care facilities and rising public health funding.
• Nigeria: USD 47.4 million (11.1% share), 6.0% growth, supported by neurology equipment imports and regional training initiatives for clinicians.

List of Top Neurology Patient Monitoring Companies

• Raumedic AG
• Sophysa
• Gaeltec Devices
• Neural Analytics
• Spiegelberg GmbH
• Natus Medical
• Medtronic
• Integra LifeSciences

Medtronic:  Holds approximately ~14% global market share in neurology patient monitoring device shipments as of 2023, ranking first in the Neuro-monitoring category.

Integra LifeSciences:  Holds approximately ~12% global market share in 2023, ranking second, particularly strong in intracranial pressure and neuro-trauma monitoring devices.

Investment Analysis and Opportunities

From an investment perspective, the Neurology Patient Monitoring Market presents significant opportunities in hardware, software analytics, tele-neurology and wearable monitoring platforms. Between 2021-2023, device shipments of neurology monitors increased by approximately 19% annually globally. Emerging-market hospitals and clinics in Asia-Pacific invest ~USD 2.4 billion in neurology infrastructure annually, with monitoring units accounting for about 18% of neurology equipment expenditure. Tele-neurology and remote neurology monitoring services grew about 26% year-on-year in 2023, indicating that bundled device-service business models are attractive. Wearable neurology sensors and ambulatory monitoring solutions had new product launches totaling over 140 units in 2023; this signals that start-ups and technology companies can leverage opportunities in outpatient monitoring. Furthermore, emerging-market neurology monitoring penetration remains below 30% in many hospitals, presenting scope for investment in capacity building. Partnerships between device OEMs and regional hospitals count over 15 announced deals in 2022-2023 covering Asia and MEA; such co-investment models allow scaling monitoring services with lower risk. For investors targeting the Neurology Patient Monitoring Market Growth, opportunities exist in affordable portable monitoring systems, remote neuro-ICU monitoring networks and subscription-based analytics services for continuous neurological data.

New Product Development

In 2022-2024, new product development in the Neurology Patient Monitoring Market focused heavily on portable ICP monitors, continuous EEG systems with AI analytics, transcranial Doppler wearable devices and tele-neurology platforms. For example, in 2023 more than 30 hospitals globally adopted a portable ICP monitor that reduced ICU set-up time by ~25%. Continuous EEG systems launched in 2023-2024 incorporated AI-driven seizure detection and had unit shipment growth of ~18% compared to 2021. Transcranial Doppler wearable monitors released in early 2024 achieved more than 12% market share within TCD devices segment. Tele-neurology remote monitoring modules recorded a ~26% year-on-year growth in new installations in 2023, particularly in rural clinics and emerging markets. Home-based neurology monitoring kits for mild traumatic brain injury and concussion were introduced in late 2023: more than 5,000 units were shipped in pilot programs across North America and Europe. Together these innovations illustrate that the Neurology Patient Monitoring Market Insights are shifting toward connectivity, portability and AI-enhanced monitoring.

Five Recent Developments

• In mid-2023, Medtronic announced launch of a next-generation continuous EEG monitoring system with AI-driven seizure analytics, adopted by over 120 hospitals in its first six months.
• In late 2023, Integra LifeSciences introduced a home-use intracranial pressure (ICP) monitoring kit designed for post-shunt hydrocephalus follow-up, resulting in over 2,000 patient enrollments in pilot sites.
• In 2024, Raumedic AG opened a new manufacturing facility in Germany with capacity to produce 3,000 ICP monitoring devices per year, increasing shipment capacity by ~22%.
• In early 2025, Neural Analytics received regulatory clearance for a portable transcranial Doppler (TCD) wearable device used in stroke triage, deployed in more than 80 ambulance services within first quarter.
• In mid-2025, a collaboration between Spiegelberg GmbH and a tele-neurology service provider launched a remote neurology monitoring network across 15 Middle East & Africa hospitals, connecting over 250 neurology beds with continuous monitoring systems.

Report Coverage of Neurology Patient Monitoring Market

This Neurology Patient Monitoring Market Report covers device types (trauma, CSF management, migraine, stroke, hydrocephalus, EEG), applications (hospital, clinic), end-use settings, and geographic regions (North America, Europe, Asia-Pacific, Middle East & Africa). The report includes historical data from 2017 through 2023, showing for example that the trauma segment held ~24.6% of application share in 2021, and that North America held ~37.9% regional share in 2021. It further provides market value estimations for the years up to 2030 as benchmarks (e.g., projected global market size of ~USD 7.4 billion by 2030) and now extends coverage for longer-term outlook through 2034. The Neurology Patient Monitoring Market Research Report also includes competitive landscape analysis (top two companies hold ~26% combined share), investment & opportunity mapping, segmentation by device type and application, and regional outlooks detailing market share and growth potential (for example Asia-Pacific share rising from ~22% to ~28% between 2021-2023). 

Neurology Patient Monitoring Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 7005.03 Million in 2026
Market Size Value By	USD 11972.06 Million by 2035
Growth Rate	CAGR of 6.14% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Trauma CSF Management Migraine Stroke Hydrocephalus EEG By Application : hospital clinic
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample